0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

NEW METHOD FOR DETERMINATION OF GALL-BLADDER FUNCTION

LLOYD A. STIRRETT, M.D.; ERIC T. YUHL, M.D.
AMA Arch Surg. 1954;68(4):417-421. doi:10.1001/archsurg.1954.01260050419003.
Text Size: A A A
Published online

INTRAVENOUS cholecystography is the most reliable method for evaluating function of the gall bladder. Introduced in 1924 by Graham and Cole,2 the technique rapidly came into widespread use. However, toxic side-reactions were not infrequently encountered. The subsequent introduction of oral contrast media which did not cause these undesirable reactions led to the abandonment of the intravenous technique. In 1948 Moore and his associates3 reported the successful use of iodinated fluorescein compounds for intravenous cholecystography.

It is the purpose of this report to describe the results obtained with a new intravenous method for the determination of gall-bladder function in a series of 102 patients. The method employs radioactive diiodofluorescein (DIF) as a tracer agent and the scintillation counter to detect the gamma radiation from the I131

METHOD  Radioactive diiodofluorescein was chosen as the tracer agent because it is rapidly removed from the blood stream and excreted in the

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();